ACC.24 Scientific Sessions
Presentations at ACC.24 Scientific Sessions (6-8 April 2024, Atlanta, USA and online) included latest updates from key trials of TG-targeting therapies including results with olezarsen from Balance in patients with Familial Chylomicronaemia Syndrome and BRIDGE-TIMI 73a in patients with hypertriglyceridaemia and high cardiovascular risk, as well as final data from SHASTA-2 in patients with severe […]
Read More > ACC.24 Scientific Sessions